Part 6 Therapy management of antibody-drug conjugates (ADC)
This Medudy Master Class Series with Prof. Sherko Kümmel is a video tutorial for physicians on the topic "Therapy of Triple-Negative Breast Cancer". Part 6 of the tutorial focuses on the therapy management of antibody-drug conjugates (ADC). The focus is on the use and handling of substances such as sacituzumab-govitecan and trastuzumab-deruxtecan. The tutorial also provides [...]
Part 5 Metastatic TNBC
This Medudy Expert Opinion with Prof. Sherko Kümmel is a video tutorial for physicians on the topic of "Treatment of metastatic triple-negative breast cancer (TNBC)". The content first highlights the historical situation in 2018, in which the prognosis for high-risk tumor biology was very poor and the median overall survival time was only 12 to 15 months. The [...]
Part 4 Practical tips for dealing with side effects of immunotherapy
This Medudy Expert Opinion with Prof. Sherko Kümmel is a video tutorial for physicians on the topic of "Practical tips for dealing with side effects of immunotherapy in triple-negative breast cancer". A comparison is made between the side effect profiles of chemotherapy and immunotherapy, emphasizing the higher variability and the involvement of different organ systems under immunotherapy. [...]
Part 3 Open questions - Triple-negative early breast cancer (eTNBC)
This Medudy Master Class Series is a video tutorial for physicians on the topic "Treatment of Triple-negative breast cancer (TNBC) in stage II and III with a focus on the role of immunotherapy", presented by Prof. Sherko Kümmel This episode deals in detail with the current treatment standards and central questions in this early stage of [...]
Part 2 Stage II+III - TNBC Focus: Role of immunotherapy
This Medudy Master Class Series is a video tutorial for physicians on the topic "Treatment of Triple-negative breast cancer (TNBC) in stage II and III with a focus on the role of immunotherapy", presented by Prof. Sherko Kümmel This episode deals in detail with the current treatment standards and central questions in this early stage of [...]
Part 1 Stage I - Triple-negative breast cancer (TNBC)
This Medudy Master Class Series is a video tutorial for physicians on the topic of "Treatment of triple-negative breast cancer (TNBC)". This first part, presented by Prof. Dr. Sherko Kümmel, highlights the treatment of stage I TNBC and discusses key questions on treatment standards, the use of neoadjuvant chemotherapy and de-escalation strategies for small tumors. A [...]
Endometrial carcinoma
This Medudy Masterclass is a five-part video tutorial for doctors on the topic of endometrial cancer. In this video series, Prof. Dr. Fabian Trillsch presents the key treatment decisions and new therapeutic approaches in endometrial cancer. The following topics are covered: The first part deals with the diagnosis of endometrial carcinoma as a basis for therapy planning. The second part [...]
Increased risk of recurrence in giant cell arteritis with mosaic loss of the Y chromosome
This Medudy course is a video tutorial for physicians on the topic "Increased risk of recurrence in giant cell arteritis with mosaic loss of the Y chromosome". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Mosaic loss of the Y chromosome (mLOY) is the most common acquired somatic [...]
The role of mLOY in giant cell arteritis
This Medudy "Expert Opinion" is a video tutorial for physicians on "The role of mLOY in giant cell arteritis" presented by Dr. Peer Aries, rheumatologist and immunologist at the Immunologikum in Hamburg. New findings on the role of mosaic loss of the Y chromosome (mLOY) in giant cell arteritis will be presented. A clinical case will be discussed and the current study situation [...]
Infections in immunocompromised patients
This Medudy Expert Opinion is a video tutorial for physicians on the topic of "Infections in immunocompromised patients" presented by Dr. Peer Aries, head of the Immunologikum in Hamburg, a specialist center for rheumatology and immunology. Patients with autoimmune diseases undergoing immunosuppressive treatment have a significantly increased risk of serious infections and infection-related deaths. Patient-related and therapy-related risk factors are discussed, [...]